Insights into the conformational perturbations of novel agonists with β3-adrenergic receptor using molecular dynamics simulations-Reference-Cited by-同舟云学术

Insights into the conformational perturbations of novel agonists with β3-adrenergic receptor using molecular dynamics simulations

Published:2014-06 Issue: Volume:101 Page:168-182
ISSN:0300-9084
Container-title:Biochimie
language:en
Short-container-title:Biochimie

Author:

Tewatia Parul,Agrawal Nikhil,Gaur Mahendra^ORCID,Sahi Shakti

Funder

Science and Engineering Research Board, Department of Science & Technology, Govt. of India

Publisher

Elsevier BV

Subject

General Medicine,Biochemistry

Reference75 articles.

1. First principles predictions of the structure and function of g-protein-coupled receptors: validation for bovine rhodopsin;Trabanino;Biophys. J.,2004

2. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise: modern homology modeling of GPCR which structure template to choose;Yarnitzky;Curr. Opin. Drug. Discov. Dev.,2010

3. Review GPCR conformations: implications for rational drug design;Parrill;Pharmaceuticals,2011

4. The structure and function of G-protein-coupled receptors;Rosenbaum;Nature,2009

5. Review: recent progress in the study of G protein-coupled receptors with molecular dynamics computer simulations;Grossfield;Biochim. Biophys. Acta,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Miquelianin, a main functional flavonoid of lotus leaf, induces thermogenic signature via p38‐PINK1‐PARKIN‐mediated mitophagy and mimicking NRF2 signaling during brown adipocyte differentiation;Food Frontiers;2023-06-25

2. G-Protein coupled receptors: structure and function in drug discovery;RSC Advances;2020

3. Recent Advances in the In-silico Structure-based and Ligand-based Approaches for the Design and Discovery of Agonists and Antagonists of A2A Adenosine Receptor;Current Pharmaceutical Design;2019-06-17

4. β3-Adrenoceptor agonists for overactive bladder syndrome: Role of translational pharmacology in a repositioning clinical drug development project;Pharmacology & Therapeutics;2016-03